Lymphocyte effector molecules: an vitro production method for obtaining liter volumes of supernatants from mitogen-stimulated human lymphocytes.
An in vitro method has been developed utilizing phytohemagglutinin (PHA) activated lymphocytes obtained from human tonsils and adenoids which permit the accumulation of multi-liter quantities of cell-free supernatants containing lymphotoxin and other lymphocyte effector molecules (LEM). An enriched media is employed which contains a large molecular weight, heat stable bovine serum fraction which supports lymphoid cell activation and levels of LEM secretion equal to that of cultures maintained in medium supplemented with whole serum. Elimination of whole serum from the media greatly reduces overall protein concentrations and facilitates concentration and purification studies. Various technical aspects of these cultures have been examined, i.e.: 1) cell concentration, 2) kinetics of LT production over a ten-day period, 3) mitogen dosage, and 4) types of media. Supernatants can be harvested repeatedly from a single culture over the ten day period, thus doubling the yield of LEM collected from a single culture.
D002470:Cell Survival; D002474:Cell-Free System; D002478:Cells, Cultured; D003470:Culture Media; D006801:Humans; D007700:Kinetics; D007962:Leukocytes; D008213:Lymphocyte Activation; D008221:Lymphoid Tissue / Q000166:cytology; D008222:Lymphokines / Q000032:analysis* / Q000096:biosynthesis; D008233:Lymphotoxin-alpha / Q000378:metabolism
D003470:Culture Media; D008222:Lymphokines; D008233:Lymphotoxin-alpha